FI71145C - Foerfarande foer framstaellning av imidazo/1,2-a/-pyridin-2-yl-karbostyrilderivat vilka aer anvaendbara som hjaertmedicin - Google Patents
Foerfarande foer framstaellning av imidazo/1,2-a/-pyridin-2-yl-karbostyrilderivat vilka aer anvaendbara som hjaertmedicin Download PDFInfo
- Publication number
- FI71145C FI71145C FI822471A FI822471A FI71145C FI 71145 C FI71145 C FI 71145C FI 822471 A FI822471 A FI 822471A FI 822471 A FI822471 A FI 822471A FI 71145 C FI71145 C FI 71145C
- Authority
- FI
- Finland
- Prior art keywords
- formula
- compound
- pyridin
- group
- alkyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 214
- -1 nitroso, amino Chemical group 0.000 claims description 110
- 125000000217 alkyl group Chemical group 0.000 claims description 57
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical group C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 claims description 47
- 239000000203 mixture Substances 0.000 claims description 39
- 229910052736 halogen Inorganic materials 0.000 claims description 26
- 150000002367 halogens Chemical class 0.000 claims description 26
- 239000003795 chemical substances by application Substances 0.000 claims description 23
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 22
- 229910052739 hydrogen Inorganic materials 0.000 claims description 20
- 239000001257 hydrogen Substances 0.000 claims description 20
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 16
- 150000003839 salts Chemical class 0.000 claims description 14
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 13
- 229910052757 nitrogen Inorganic materials 0.000 claims description 13
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 13
- 238000002360 preparation method Methods 0.000 claims description 12
- 125000005843 halogen group Chemical group 0.000 claims description 11
- 150000002431 hydrogen Chemical class 0.000 claims description 11
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 11
- 125000005236 alkanoylamino group Chemical group 0.000 claims description 9
- 125000003545 alkoxy group Chemical group 0.000 claims description 9
- 125000003282 alkyl amino group Chemical group 0.000 claims description 9
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 8
- 235000019253 formic acid Nutrition 0.000 claims description 8
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 claims description 7
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 7
- 230000000747 cardiac effect Effects 0.000 claims description 7
- 229910052783 alkali metal Inorganic materials 0.000 claims description 6
- 125000005945 imidazopyridyl group Chemical group 0.000 claims description 6
- 125000003342 alkenyl group Chemical group 0.000 claims description 5
- 125000000304 alkynyl group Chemical group 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 238000009472 formulation Methods 0.000 claims description 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 5
- 125000000018 nitroso group Chemical group N(=O)* 0.000 claims description 5
- 229910052740 iodine Inorganic materials 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 2
- 125000001589 carboacyl group Chemical group 0.000 claims description 2
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims description 2
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 2
- 244000108452 Litchi chinensis Species 0.000 claims 1
- 235000015742 Nephelium litchi Nutrition 0.000 claims 1
- 125000005606 carbostyryl group Chemical group 0.000 claims 1
- 125000005647 linker group Chemical group 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 96
- 238000006243 chemical reaction Methods 0.000 description 92
- ICSNLGPSRYBMBD-UHFFFAOYSA-N 2-aminopyridine Chemical compound NC1=CC=CC=N1 ICSNLGPSRYBMBD-UHFFFAOYSA-N 0.000 description 89
- 239000013078 crystal Substances 0.000 description 71
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 70
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 63
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 58
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 56
- 239000002904 solvent Substances 0.000 description 49
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 48
- 239000000243 solution Substances 0.000 description 46
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 42
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 39
- 238000001914 filtration Methods 0.000 description 35
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 26
- 239000002253 acid Substances 0.000 description 26
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 24
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 23
- 239000000843 powder Substances 0.000 description 23
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 22
- 239000011541 reaction mixture Substances 0.000 description 21
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 18
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 18
- MDKXBBPLEGPIRI-UHFFFAOYSA-N ethoxyethane;methanol Chemical compound OC.CCOCC MDKXBBPLEGPIRI-UHFFFAOYSA-N 0.000 description 18
- 238000010992 reflux Methods 0.000 description 18
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 16
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 16
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 16
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 14
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 13
- 150000007514 bases Chemical class 0.000 description 13
- 235000011121 sodium hydroxide Nutrition 0.000 description 13
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- WFDIJRYMOXRFFG-UHFFFAOYSA-N acetic acid anhydride Natural products CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 12
- 150000007513 acids Chemical class 0.000 description 12
- 238000001816 cooling Methods 0.000 description 12
- 230000002140 halogenating effect Effects 0.000 description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 11
- 239000003054 catalyst Substances 0.000 description 11
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 10
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 10
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 10
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 10
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 10
- 239000000725 suspension Substances 0.000 description 10
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 238000005658 halogenation reaction Methods 0.000 description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 8
- CMGSKKCWNZSKSM-UHFFFAOYSA-N 6-(3-ethylimidazo[1,2-a]pyridin-2-yl)-3,4-dihydro-1H-quinolin-2-one Chemical compound N1C(=O)CCC2=CC(C3=C(N4C=CC=CC4=N3)CC)=CC=C21 CMGSKKCWNZSKSM-UHFFFAOYSA-N 0.000 description 8
- WGAXHNCYQGQGKI-UHFFFAOYSA-N CN(C)CC1=C(N=C2N1C=CC=C2)C3=CC4=C(C=C3)NC(=O)CC4 Chemical compound CN(C)CC1=C(N=C2N1C=CC=C2)C3=CC4=C(C=C3)NC(=O)CC4 WGAXHNCYQGQGKI-UHFFFAOYSA-N 0.000 description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 239000002585 base Substances 0.000 description 8
- 150000004820 halides Chemical class 0.000 description 8
- 229910000029 sodium carbonate Inorganic materials 0.000 description 8
- 235000017550 sodium carbonate Nutrition 0.000 description 8
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 8
- 239000007858 starting material Substances 0.000 description 8
- TZOYXRMEFDYWDQ-UHFFFAOYSA-N 3,4-dihydro-1h-quinolin-2-one Chemical compound C1=CC=C2NC(=O)CCC2=C1 TZOYXRMEFDYWDQ-UHFFFAOYSA-N 0.000 description 7
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 7
- 239000002841 Lewis acid Substances 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 7
- 229910052794 bromium Inorganic materials 0.000 description 7
- 125000004432 carbon atom Chemical group C* 0.000 description 7
- 150000007517 lewis acids Chemical class 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 238000006722 reduction reaction Methods 0.000 description 7
- 239000000741 silica gel Substances 0.000 description 7
- 229910002027 silica gel Inorganic materials 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 150000008064 anhydrides Chemical class 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 6
- 239000005457 ice water Substances 0.000 description 6
- 239000012442 inert solvent Substances 0.000 description 6
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 6
- FIPPIBNNPHZUIA-UHFFFAOYSA-N 1-methyl-6-(3-methylimidazo[1,2-a]pyridin-2-yl)-3,4-dihydroquinolin-2-one;hydrobromide Chemical compound Br.N1=C2C=CC=CN2C(C)=C1C1=CC=C2N(C)C(=O)CCC2=C1 FIPPIBNNPHZUIA-UHFFFAOYSA-N 0.000 description 5
- CASCQMUJAGLXIY-UHFFFAOYSA-N CC1=CC2=NC(=C(N2C=C1)C)C3=CC4=C(C=C3)NC(=O)CC4 Chemical compound CC1=CC2=NC(=C(N2C=C1)C)C3=CC4=C(C=C3)NC(=O)CC4 CASCQMUJAGLXIY-UHFFFAOYSA-N 0.000 description 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 5
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 5
- 238000005917 acylation reaction Methods 0.000 description 5
- 150000001298 alcohols Chemical class 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 239000000460 chlorine Substances 0.000 description 5
- 229910052801 chlorine Inorganic materials 0.000 description 5
- 230000026030 halogenation Effects 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- 229910000027 potassium carbonate Inorganic materials 0.000 description 5
- 235000011181 potassium carbonates Nutrition 0.000 description 5
- 235000019260 propionic acid Nutrition 0.000 description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 5
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 4
- UGSBCCAHDVCHGI-UHFFFAOYSA-N 5-nitropyridin-2-amine Chemical compound NC1=CC=C([N+]([O-])=O)C=N1 UGSBCCAHDVCHGI-UHFFFAOYSA-N 0.000 description 4
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 4
- 241000282472 Canis lupus familiaris Species 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 4
- 150000002170 ethers Chemical class 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 150000008282 halocarbons Chemical class 0.000 description 4
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 4
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 4
- 229910017604 nitric acid Inorganic materials 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- 235000011118 potassium hydroxide Nutrition 0.000 description 4
- LJZPPWWHKPGCHS-UHFFFAOYSA-N propargyl chloride Chemical compound ClCC#C LJZPPWWHKPGCHS-UHFFFAOYSA-N 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 235000010288 sodium nitrite Nutrition 0.000 description 4
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- 239000011135 tin Substances 0.000 description 4
- 229910052718 tin Inorganic materials 0.000 description 4
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- BMTSZVZQNMNPCT-UHFFFAOYSA-N 2-aminopyridin-3-ol Chemical compound NC1=NC=CC=C1O BMTSZVZQNMNPCT-UHFFFAOYSA-N 0.000 description 3
- RGDQRXPEZUNWHX-UHFFFAOYSA-N 3-methylpyridin-2-amine Chemical compound CC1=CC=CN=C1N RGDQRXPEZUNWHX-UHFFFAOYSA-N 0.000 description 3
- GKCLLNRJRIHPAJ-UHFFFAOYSA-N 5-(3-ethylimidazo[1,2-a]pyridin-2-yl)-8-methoxy-3,4-dihydro-1h-quinolin-2-one;hydrobromide Chemical compound Br.N1C(=O)CCC2=C1C(OC)=CC=C2C1=C(CC)N2C=CC=CC2=N1 GKCLLNRJRIHPAJ-UHFFFAOYSA-N 0.000 description 3
- MAXBVGJEFDMHNV-UHFFFAOYSA-N 5-chloropyridin-2-amine Chemical compound NC1=CC=C(Cl)C=N1 MAXBVGJEFDMHNV-UHFFFAOYSA-N 0.000 description 3
- ZTUCCIVGITUIAS-UHFFFAOYSA-N 5-imidazo[1,2-a]pyridin-2-yl-8-methoxy-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CC(=O)NC2=C1C(C=1N=C3C=CC=CN3C=1)=CC=C2OC ZTUCCIVGITUIAS-UHFFFAOYSA-N 0.000 description 3
- ULEFEAILJGDMDP-UHFFFAOYSA-N 6-(3-methylimidazo[1,2-a]pyridin-2-yl)-3,4-dihydro-1h-quinolin-2-one;hydrobromide Chemical compound Br.N1C(=O)CCC2=CC(C3=C(N4C=CC=CC4=N3)C)=CC=C21 ULEFEAILJGDMDP-UHFFFAOYSA-N 0.000 description 3
- MBCZEGOCEBUUBY-UHFFFAOYSA-N 6-imidazo[1,2-a]pyridin-2-yl-1h-quinolin-2-one;hydrochloride Chemical compound Cl.C1=CC=CC2=NC(C=3C=C4C=CC(NC4=CC=3)=O)=CN21 MBCZEGOCEBUUBY-UHFFFAOYSA-N 0.000 description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 3
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical class BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 239000007868 Raney catalyst Substances 0.000 description 3
- 229910000564 Raney nickel Inorganic materials 0.000 description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 150000001340 alkali metals Chemical class 0.000 description 3
- 239000002168 alkylating agent Substances 0.000 description 3
- 229940100198 alkylating agent Drugs 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 239000012954 diazonium Substances 0.000 description 3
- 150000001989 diazonium salts Chemical class 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- 239000011737 fluorine Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 3
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 3
- 238000005984 hydrogenation reaction Methods 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- NIQQIJXGUZVEBB-UHFFFAOYSA-N methanol;propan-2-one Chemical compound OC.CC(C)=O NIQQIJXGUZVEBB-UHFFFAOYSA-N 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 150000007530 organic bases Chemical class 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 210000005245 right atrium Anatomy 0.000 description 3
- 239000001632 sodium acetate Substances 0.000 description 3
- 235000017281 sodium acetate Nutrition 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 2
- QPFMBZIOSGYJDE-UHFFFAOYSA-N 1,1,2,2-tetrachloroethane Chemical compound ClC(Cl)C(Cl)Cl QPFMBZIOSGYJDE-UHFFFAOYSA-N 0.000 description 2
- KHKISGKYDUSMEB-UHFFFAOYSA-N 1-benzyl-5-imidazo[1,2-a]pyridin-2-yl-8-methoxy-3,4-dihydroquinolin-2-one;hydrate;hydrochloride Chemical compound O.Cl.C1=2C(OC)=CC=C(C=3N=C4C=CC=CN4C=3)C=2CCC(=O)N1CC1=CC=CC=C1 KHKISGKYDUSMEB-UHFFFAOYSA-N 0.000 description 2
- XVBGIBICVOOFJF-UHFFFAOYSA-N 2-[2-(8-methoxy-2-oxo-1h-quinolin-5-yl)imidazo[1,2-a]pyridin-3-yl]acetonitrile Chemical compound C1=CC(=O)NC2=C1C(C1=C(N3C=CC=CC3=N1)CC#N)=CC=C2OC XVBGIBICVOOFJF-UHFFFAOYSA-N 0.000 description 2
- WJMJWMSWJSACSN-UHFFFAOYSA-N 3,5-dibromopyridin-2-amine Chemical compound NC1=NC=C(Br)C=C1Br WJMJWMSWJSACSN-UHFFFAOYSA-N 0.000 description 2
- HNAYRVKSWGSQTP-UHFFFAOYSA-N 3-methoxypyridin-2-amine Chemical compound COC1=CC=CN=C1N HNAYRVKSWGSQTP-UHFFFAOYSA-N 0.000 description 2
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 2
- ORLGLBZRQYOWNA-UHFFFAOYSA-N 4-methylpyridin-2-amine Chemical compound CC1=CC=NC(N)=C1 ORLGLBZRQYOWNA-UHFFFAOYSA-N 0.000 description 2
- MRGNVJDXYOQCJZ-UHFFFAOYSA-N 5-(2-chloroacetyl)-8-methoxy-1h-quinolin-2-one Chemical compound C1=CC(=O)NC2=C1C(C(=O)CCl)=CC=C2OC MRGNVJDXYOQCJZ-UHFFFAOYSA-N 0.000 description 2
- MMACJHLHUBIBLC-UHFFFAOYSA-N 5-(3,7-dimethylimidazo[1,2-a]pyridin-2-yl)-8-methoxy-1h-quinolin-2-one;hydrate;hydrobromide Chemical compound O.Br.C1=CC(=O)NC2=C1C(C1=C(N3C=CC(C)=CC3=N1)C)=CC=C2OC MMACJHLHUBIBLC-UHFFFAOYSA-N 0.000 description 2
- ASGJSKSBXBEQQG-UHFFFAOYSA-N 5-(6,8-dibromo-3-methylimidazo[1,2-a]pyridin-2-yl)-8-methoxy-1h-quinolin-2-one;hydrobromide Chemical compound Br.C1=CC(=O)NC2=C1C(C1=C(N3C=C(Br)C=C(Br)C3=N1)C)=CC=C2OC ASGJSKSBXBEQQG-UHFFFAOYSA-N 0.000 description 2
- UUANRULAAKGHSM-UHFFFAOYSA-N 5-(6-chloroimidazo[1,2-a]pyridin-2-yl)-8-methoxy-1h-quinolin-2-one;dihydrate;hydrochloride Chemical compound O.O.Cl.C1=CC(=O)NC2=C1C(C=1N=C3C=CC(Cl)=CN3C=1)=CC=C2OC UUANRULAAKGHSM-UHFFFAOYSA-N 0.000 description 2
- NFUOOPWVEGOETI-UHFFFAOYSA-N 5-imidazo[1,2-a]pyridin-2-yl-8-methoxy-1-prop-2-ynyl-3,4-dihydroquinolin-2-one;hydrochloride Chemical compound Cl.C1CC(=O)N(CC#C)C2=C1C(C=1N=C3C=CC=CN3C=1)=CC=C2OC NFUOOPWVEGOETI-UHFFFAOYSA-N 0.000 description 2
- QDSXDCWQCOQONL-UHFFFAOYSA-N 5-imidazo[1,2-a]pyridin-2-yl-8-methoxy-1h-quinolin-2-one Chemical compound C1=CC(=O)NC2=C1C(C=1N=C3C=CC=CN3C=1)=CC=C2OC QDSXDCWQCOQONL-UHFFFAOYSA-N 0.000 description 2
- CIORMRKKYWKKCL-UHFFFAOYSA-N 6-(3,7-dimethylimidazo[1,2-a]pyridin-2-yl)-1h-quinolin-2-one;hydrochloride Chemical compound Cl.N1C(=O)C=CC2=CC(C3=C(N4C=CC(C)=CC4=N3)C)=CC=C21 CIORMRKKYWKKCL-UHFFFAOYSA-N 0.000 description 2
- QFTZFEXPIMJWGC-UHFFFAOYSA-N 6-(3-ethylimidazo[1,2-a]pyridin-2-yl)-1-prop-2-ynylquinolin-2-one hydrochloride Chemical compound Cl.C#CCN1C(=O)C=CC2=CC(C3=C(N4C=CC=CC4=N3)CC)=CC=C21 QFTZFEXPIMJWGC-UHFFFAOYSA-N 0.000 description 2
- BEQUXNICZIDGES-UHFFFAOYSA-N 6-(3-ethylimidazo[1,2-a]pyridin-2-yl)-3,4-dihydro-1h-quinolin-2-one;hydrobromide Chemical compound Br.N1C(=O)CCC2=CC(C3=C(N4C=CC=CC4=N3)CC)=CC=C21 BEQUXNICZIDGES-UHFFFAOYSA-N 0.000 description 2
- FKFCMYUBIRDGPC-UHFFFAOYSA-N 6-(3-nitrosoimidazo[1,2-a]pyridin-2-yl)-1h-quinolin-2-one Chemical compound N1C(=O)C=CC2=CC(C3=C(N4C=CC=CC4=N3)N=O)=CC=C21 FKFCMYUBIRDGPC-UHFFFAOYSA-N 0.000 description 2
- DZZZNCVAHASGOU-UHFFFAOYSA-N 6-[3-[(dimethylamino)methyl]imidazo[1,2-a]pyridin-2-yl]-1h-quinolin-2-one;trihydrate;dihydrochloride Chemical compound O.O.O.Cl.Cl.N1C(=O)C=CC2=CC(C3=C(N4C=CC=CC4=N3)CN(C)C)=CC=C21 DZZZNCVAHASGOU-UHFFFAOYSA-N 0.000 description 2
- OJKCAYLVBFIFNU-UHFFFAOYSA-N 6-acetyl-8-methoxy-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CC(=O)NC2=C1C=C(C(C)=O)C=C2OC OJKCAYLVBFIFNU-UHFFFAOYSA-N 0.000 description 2
- ZEOZWANWDVJSSK-UHFFFAOYSA-N 6-imidazo[1,2-a]pyridin-2-yl-8-methoxy-3,4-dihydro-1h-quinolin-2-one;hydrobromide Chemical compound Br.C1=CC=CC2=NC(C=3C=C(C=4NC(=O)CCC=4C=3)OC)=CN21 ZEOZWANWDVJSSK-UHFFFAOYSA-N 0.000 description 2
- QUXLCYFNVNNRBE-UHFFFAOYSA-N 6-methylpyridin-2-amine Chemical compound CC1=CC=CC(N)=N1 QUXLCYFNVNNRBE-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- QMJYZUUKWOKUEI-UHFFFAOYSA-N 8-chloro-6-imidazo[1,2-a]pyridin-2-yl-3,4-dihydro-1h-quinolin-2-one;hydrochloride Chemical compound Cl.C1=CC=CC2=NC(C=3C=C(C=4NC(=O)CCC=4C=3)Cl)=CN21 QMJYZUUKWOKUEI-UHFFFAOYSA-N 0.000 description 2
- YAKYKFNYTQBDOW-UHFFFAOYSA-N 8-hydroxy-6-nitro-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CC(=O)NC2=C1C=C([N+]([O-])=O)C=C2O YAKYKFNYTQBDOW-UHFFFAOYSA-N 0.000 description 2
- MPCNPWIPIUZBBJ-UHFFFAOYSA-N 8-methoxy-5-(3-methylimidazo[1,2-a]pyridin-2-yl)-3,4-dihydro-1h-quinolin-2-one;hydrobromide Chemical compound Br.C1CC(=O)NC2=C1C(C1=C(N3C=CC=CC3=N1)C)=CC=C2OC MPCNPWIPIUZBBJ-UHFFFAOYSA-N 0.000 description 2
- MFKQIGDCKKWQCW-UHFFFAOYSA-N 8-methoxy-5-(3-nitrosoimidazo[1,2-a]pyridin-2-yl)-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CC(=O)NC2=C1C(C1=C(N3C=CC=CC3=N1)N=O)=CC=C2OC MFKQIGDCKKWQCW-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 239000004342 Benzoyl peroxide Substances 0.000 description 2
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 2
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 2
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 2
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 230000010933 acylation Effects 0.000 description 2
- 150000001350 alkyl halides Chemical class 0.000 description 2
- 150000001351 alkyl iodides Chemical class 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- 230000001746 atrial effect Effects 0.000 description 2
- 235000019400 benzoyl peroxide Nutrition 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 238000006193 diazotization reaction Methods 0.000 description 2
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- GVLGAFRNYJVHBC-UHFFFAOYSA-N hydrate;hydrobromide Chemical compound O.Br GVLGAFRNYJVHBC-UHFFFAOYSA-N 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- 239000003999 initiator Substances 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 2
- 125000002183 isoquinolinyl group Chemical class C1(=NC=CC2=CC=CC=C12)* 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 2
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000000802 nitrating effect Effects 0.000 description 2
- 238000006396 nitration reaction Methods 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 2
- 239000004533 oil dispersion Substances 0.000 description 2
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 229910003446 platinum oxide Inorganic materials 0.000 description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 description 2
- 239000011736 potassium bicarbonate Substances 0.000 description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 description 2
- 238000007348 radical reaction Methods 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 235000010265 sodium sulphite Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000001119 stannous chloride Substances 0.000 description 2
- 235000011150 stannous chloride Nutrition 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 239000011592 zinc chloride Substances 0.000 description 2
- 235000005074 zinc chloride Nutrition 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- LQWLOKULNGQEOJ-UHFFFAOYSA-N (6-nitro-2-oxo-3,4-dihydro-1h-quinolin-8-yl) acetate Chemical compound C1CC(=O)NC2=C1C=C([N+]([O-])=O)C=C2OC(=O)C LQWLOKULNGQEOJ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 description 1
- FTTATHOUSOIFOQ-UHFFFAOYSA-N 1,2,3,4,6,7,8,8a-octahydropyrrolo[1,2-a]pyrazine Chemical compound C1NCCN2CCCC21 FTTATHOUSOIFOQ-UHFFFAOYSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- OGFAWKRXZLGJSK-UHFFFAOYSA-N 1-(2,4-dihydroxyphenyl)-2-(4-nitrophenyl)ethanone Chemical compound OC1=CC(O)=CC=C1C(=O)CC1=CC=C([N+]([O-])=O)C=C1 OGFAWKRXZLGJSK-UHFFFAOYSA-N 0.000 description 1
- 125000006030 1-methyl-3-butenyl group Chemical group 0.000 description 1
- 125000006052 1-methyl-3-pentenyl group Chemical group 0.000 description 1
- 125000006055 1-methyl-4-pentenyl group Chemical group 0.000 description 1
- 125000004343 1-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- JCCMFLJZAZOWAG-UHFFFAOYSA-N 2-[2-(8-methoxy-2-oxo-1H-quinolin-5-yl)imidazo[1,2-a]pyridin-3-yl]acetamide hydrochloride Chemical compound Cl.C1=CC(=O)NC2=C1C(C1=C(N3C=CC=CC3=N1)CC(N)=O)=CC=C2OC JCCMFLJZAZOWAG-UHFFFAOYSA-N 0.000 description 1
- OJDRLKGZEOAABF-UHFFFAOYSA-N 2-[2-(8-methoxy-2-oxo-1h-quinolin-5-yl)imidazo[1,2-a]pyridin-3-yl]acetamide Chemical compound C1=CC(=O)NC2=C1C(C1=C(N3C=CC=CC3=N1)CC(N)=O)=CC=C2OC OJDRLKGZEOAABF-UHFFFAOYSA-N 0.000 description 1
- OPTCDWKPCZKBKX-UHFFFAOYSA-N 2-[2-(8-methoxy-2-oxo-1h-quinolin-5-yl)imidazo[1,2-a]pyridin-3-yl]acetic acid Chemical compound C1=CC(=O)NC2=C1C(C1=C(N3C=CC=CC3=N1)CC(O)=O)=CC=C2OC OPTCDWKPCZKBKX-UHFFFAOYSA-N 0.000 description 1
- ILLHORFDXDLILE-UHFFFAOYSA-N 2-bromopropanoyl bromide Chemical compound CC(Br)C(Br)=O ILLHORFDXDLILE-UHFFFAOYSA-N 0.000 description 1
- 125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 description 1
- 125000006040 2-hexenyl group Chemical group 0.000 description 1
- LUTLHMAEGAVZRP-UHFFFAOYSA-N 2-hydroxy-2-methylpropanenitrile;nitric acid Chemical compound O[N+]([O-])=O.CC(C)(O)C#N LUTLHMAEGAVZRP-UHFFFAOYSA-N 0.000 description 1
- 125000006053 2-methyl-3-pentenyl group Chemical group 0.000 description 1
- 125000006056 2-methyl-4-pentenyl group Chemical group 0.000 description 1
- 125000006024 2-pentenyl group Chemical group 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- 125000000474 3-butynyl group Chemical group [H]C#CC([H])([H])C([H])([H])* 0.000 description 1
- 125000006041 3-hexenyl group Chemical group 0.000 description 1
- AANBPMVMIOZKSZ-UHFFFAOYSA-N 3-imidazo[1,2-a]pyridin-2-yl-1H-quinolin-2-one Chemical class N=1C(=CN2C=1C=CC=C2)C=1C(NC2=CC=CC=C2C=1)=O AANBPMVMIOZKSZ-UHFFFAOYSA-N 0.000 description 1
- IWBDTVTUJSTDPU-UHFFFAOYSA-N 3-methoxy-1h-quinolin-2-one Chemical compound C1=CC=C2NC(=O)C(OC)=CC2=C1 IWBDTVTUJSTDPU-UHFFFAOYSA-N 0.000 description 1
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000006042 4-hexenyl group Chemical group 0.000 description 1
- ZXYHUDMEPGYCDF-UHFFFAOYSA-N 5-(2-chloroacetyl)-8-hydroxy-1h-quinolin-2-one Chemical compound C1=CC(=O)NC2=C1C(C(=O)CCl)=CC=C2O ZXYHUDMEPGYCDF-UHFFFAOYSA-N 0.000 description 1
- JVIONGQLJPDREA-UHFFFAOYSA-N 5-(3-aminoimidazo[1,2-a]pyridin-2-yl)-8-methoxy-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CC(=O)NC2=C1C(C1=C(N3C=CC=CC3=N1)N)=CC=C2OC JVIONGQLJPDREA-UHFFFAOYSA-N 0.000 description 1
- LDTWUCRRUJCSQK-UHFFFAOYSA-N 5-(3-bromopropanoyl)-8-methoxy-1H-quinolin-2-one Chemical compound COC=1C=CC(=C2C=CC(NC=12)=O)C(CCBr)=O LDTWUCRRUJCSQK-UHFFFAOYSA-N 0.000 description 1
- WSYKCARUPPPYTO-UHFFFAOYSA-N 5-(3-bromopropanoyl)-8-methoxy-3,4-dihydro-1H-quinolin-2-one Chemical compound COC1=C2NC(=O)CCC2=C(C=C1)C(=O)CCBr WSYKCARUPPPYTO-UHFFFAOYSA-N 0.000 description 1
- ATMOYQJNRCQGHQ-UHFFFAOYSA-N 5-(3-ethylimidazo[1,2-a]pyridin-2-yl)-8-methoxy-1H-quinolin-2-one hydrobromide Chemical compound Br.N1C(=O)C=CC2=C1C(OC)=CC=C2C1=C(CC)N2C=CC=CC2=N1 ATMOYQJNRCQGHQ-UHFFFAOYSA-N 0.000 description 1
- FUEGAYJBDUCQJE-UHFFFAOYSA-N 5-(3-ethylimidazo[1,2-a]pyridin-2-yl)-8-methoxy-1h-quinolin-2-one Chemical compound N1C(=O)C=CC2=C1C(OC)=CC=C2C1=C(CC)N2C=CC=CC2=N1 FUEGAYJBDUCQJE-UHFFFAOYSA-N 0.000 description 1
- KRFCNZDLKPORLV-UHFFFAOYSA-N 5-(8-hydroxy-3-methylimidazo[1,2-a]pyridin-2-yl)-8-methoxy-1h-quinolin-2-one;hydrochloride Chemical compound Cl.C1=CC(=O)NC2=C1C(C1=C(N3C=CC=C(O)C3=N1)C)=CC=C2OC KRFCNZDLKPORLV-UHFFFAOYSA-N 0.000 description 1
- RGATYROIAGETLH-UHFFFAOYSA-N 5-(8-hydroxyimidazo[1,2-a]pyridin-2-yl)-8-methoxy-1h-quinolin-2-one Chemical compound C1=CC(=O)NC2=C1C(C=1N=C3C(O)=CC=CN3C=1)=CC=C2OC RGATYROIAGETLH-UHFFFAOYSA-N 0.000 description 1
- YVZCHEPJHIVAAN-UHFFFAOYSA-N 5-(8-hydroxyimidazo[1,2-a]pyridin-2-yl)-8-methoxy-1h-quinolin-2-one;hydrochloride Chemical compound Cl.C1=CC(=O)NC2=C1C(C=1N=C3C(O)=CC=CN3C=1)=CC=C2OC YVZCHEPJHIVAAN-UHFFFAOYSA-N 0.000 description 1
- BONWOOCRQUCDRP-UHFFFAOYSA-N 5-[3-(dimethylamino)imidazo[1,2-a]pyridin-2-yl]-8-methoxy-1H-quinolin-2-one Chemical compound C1=CC(=O)NC2=C1C(C1=C(N3C=CC=CC3=N1)N(C)C)=CC=C2OC BONWOOCRQUCDRP-UHFFFAOYSA-N 0.000 description 1
- HNIDBJUIXQPJKN-UHFFFAOYSA-N 5-[3-(dimethylamino)imidazo[1,2-a]pyridin-2-yl]-8-methoxy-3,4-dihydro-1h-quinolin-2-one;hydrochloride Chemical compound Cl.C1CC(=O)NC2=C1C(C1=C(N3C=CC=CC3=N1)N(C)C)=CC=C2OC HNIDBJUIXQPJKN-UHFFFAOYSA-N 0.000 description 1
- BHQSKQDJRYAGPV-UHFFFAOYSA-N 5-[3-[(dimethylamino)methyl]imidazo[1,2-a]pyridin-2-yl]-8-methoxy-1h-quinolin-2-one Chemical compound C1=CC(=O)NC2=C1C(C1=C(N3C=CC=CC3=N1)CN(C)C)=CC=C2OC BHQSKQDJRYAGPV-UHFFFAOYSA-N 0.000 description 1
- GFHYSLDCJWQTDX-UHFFFAOYSA-N 5-[3-[(dimethylamino)methyl]imidazo[1,2-a]pyridin-2-yl]-8-methoxy-1h-quinolin-2-one;trihydrate;dihydrochloride Chemical compound O.O.O.Cl.Cl.C1=CC(=O)NC2=C1C(C1=C(N3C=CC=CC3=N1)CN(C)C)=CC=C2OC GFHYSLDCJWQTDX-UHFFFAOYSA-N 0.000 description 1
- VNHBYKHXBCYPBJ-UHFFFAOYSA-N 5-ethynylimidazo[1,2-a]pyridine Chemical compound C#CC1=CC=CC2=NC=CN12 VNHBYKHXBCYPBJ-UHFFFAOYSA-N 0.000 description 1
- 125000006043 5-hexenyl group Chemical group 0.000 description 1
- KOWVDYHTRNJNHA-UHFFFAOYSA-N 5-imidazo[1,2-a]pyridin-2-yl-8-methoxy-1-methyl-3,4-dihydroquinolin-2-one;hydrate;hydrochloride Chemical compound O.Cl.C1CC(=O)N(C)C2=C1C(C=1N=C3C=CC=CN3C=1)=CC=C2OC KOWVDYHTRNJNHA-UHFFFAOYSA-N 0.000 description 1
- XWINOZRLIQTIHT-UHFFFAOYSA-N 5-imidazo[1,2-a]pyridin-2-yl-8-methoxy-1-methyl-3,4-dihydroquinolin-2-one;hydrochloride Chemical compound Cl.C1CC(=O)N(C)C2=C1C(C=1N=C3C=CC=CN3C=1)=CC=C2OC XWINOZRLIQTIHT-UHFFFAOYSA-N 0.000 description 1
- ZETMLDCOQDJOTA-UHFFFAOYSA-N 5-imidazo[1,2-a]pyridin-2-yl-8-methoxy-1-prop-2-ynylquinolin-2-one;hydrochloride Chemical compound Cl.C1=CC(=O)N(CC#C)C2=C1C(C=1N=C3C=CC=CN3C=1)=CC=C2OC ZETMLDCOQDJOTA-UHFFFAOYSA-N 0.000 description 1
- SKGADJLADDCETA-UHFFFAOYSA-N 5-imidazo[1,2-a]pyridin-2-yl-8-methoxy-1h-quinolin-2-one;hydrate;hydrochloride Chemical compound O.Cl.C1=CC(=O)NC2=C1C(C=1N=C3C=CC=CN3C=1)=CC=C2OC SKGADJLADDCETA-UHFFFAOYSA-N 0.000 description 1
- NBVICRLOBHHWGJ-UHFFFAOYSA-N 5-imidazo[1,2-a]pyridin-2-yl-8-methoxy-3,4-dihydro-1h-quinolin-2-one;hydrochloride Chemical compound Cl.C1CC(=O)NC2=C1C(C=1N=C3C=CC=CN3C=1)=CC=C2OC NBVICRLOBHHWGJ-UHFFFAOYSA-N 0.000 description 1
- ZDZLUAJGHKSFEJ-UHFFFAOYSA-N 6-(2-chloroacetyl)-1h-quinolin-2-one Chemical compound N1C(=O)C=CC2=CC(C(=O)CCl)=CC=C21 ZDZLUAJGHKSFEJ-UHFFFAOYSA-N 0.000 description 1
- MJNWCDIKASDSAG-UHFFFAOYSA-N 6-(3-ethylimidazo[1,2-a]pyridin-2-yl)-1-prop-2-ynyl-3,4-dihydroquinolin-2-one hydrochloride Chemical compound CCC1=C(N=C2N1C=CC=C2)C3=CC4=C(C=C3)N(C(=O)CC4)CC#C.Cl MJNWCDIKASDSAG-UHFFFAOYSA-N 0.000 description 1
- UTDUJWGSFOTUHP-UHFFFAOYSA-N 6-(3-ethylimidazo[1,2-a]pyridin-2-yl)-1-prop-2-ynyl-3,4-dihydroquinolin-2-one;hydrate;hydrochloride Chemical compound O.Cl.C#CCN1C(=O)CCC2=CC(C3=C(N4C=CC=CC4=N3)CC)=CC=C21 UTDUJWGSFOTUHP-UHFFFAOYSA-N 0.000 description 1
- UPKGEVIUZIVSIG-UHFFFAOYSA-N 6-(3-ethylimidazo[1,2-a]pyridin-2-yl)-1h-quinolin-2-one Chemical compound N1C(=O)C=CC2=CC(C3=C(N4C=CC=CC4=N3)CC)=CC=C21 UPKGEVIUZIVSIG-UHFFFAOYSA-N 0.000 description 1
- YIOWMCZOLPCNIC-UHFFFAOYSA-N 6-(3-ethylimidazo[1,2-a]pyridin-2-yl)-1h-quinolin-2-one;hydrate;hydrobromide Chemical compound O.Br.N1C(=O)C=CC2=CC(C3=C(N4C=CC=CC4=N3)CC)=CC=C21 YIOWMCZOLPCNIC-UHFFFAOYSA-N 0.000 description 1
- NUBASIBQBROOTF-UHFFFAOYSA-N 6-(3-methylimidazo[1,2-a]pyridin-2-yl)-3,4-dihydro-1h-quinolin-2-one Chemical compound N1C(=O)CCC2=CC(C3=C(N4C=CC=CC4=N3)C)=CC=C21 NUBASIBQBROOTF-UHFFFAOYSA-N 0.000 description 1
- FKSIJIRBJZNGHP-UHFFFAOYSA-N 6-(5-methylimidazo[1,2-a]pyridin-2-yl)-1h-quinolin-2-one;hydrochloride Chemical compound Cl.N1C(=O)C=CC2=CC(C=3N=C4C=CC=C(N4C=3)C)=CC=C21 FKSIJIRBJZNGHP-UHFFFAOYSA-N 0.000 description 1
- VWLKSGLAMATFBU-UHFFFAOYSA-N 6-amino-8-methoxy-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CC(=O)NC2=C1C=C(N)C=C2OC VWLKSGLAMATFBU-UHFFFAOYSA-N 0.000 description 1
- URXGXHRLUBYYQL-UHFFFAOYSA-N 6-imidazo[1,2-a]pyridin-2-yl-1-prop-2-ynylquinolin-2-one Chemical compound C1=CC=CC2=NC(C=3C=C4C=CC(N(C4=CC=3)CC#C)=O)=CN21 URXGXHRLUBYYQL-UHFFFAOYSA-N 0.000 description 1
- FNWSQBZWUGLOLK-UHFFFAOYSA-N 6-imidazo[1,2-a]pyridin-2-yl-1-prop-2-ynylquinolin-2-one hydrochloride Chemical compound Cl.C1=CC=CC2=NC(C=3C=C4C=CC(N(C4=CC=3)CC#C)=O)=CN21 FNWSQBZWUGLOLK-UHFFFAOYSA-N 0.000 description 1
- FXXBZYRXEQAGHO-UHFFFAOYSA-N 6-imidazo[1,2-a]pyridin-2-yl-1h-quinolin-2-one Chemical compound C1=CC=CC2=NC(C=3C=C4C=CC(NC4=CC=3)=O)=CN21 FXXBZYRXEQAGHO-UHFFFAOYSA-N 0.000 description 1
- YPLMHQHMGYAPGW-UHFFFAOYSA-N 6-imidazo[1,2-a]pyridin-2-yl-3,4-dihydro-1h-quinolin-2-one Chemical compound C1=CC=CC2=NC(C=3C=C4CCC(NC4=CC=3)=O)=CN21 YPLMHQHMGYAPGW-UHFFFAOYSA-N 0.000 description 1
- QGMUHSFQVFTNGH-UHFFFAOYSA-N 6-imidazo[1,2-a]pyridin-2-yl-8-methyl-3,4-dihydro-1H-quinolin-2-one hydrochloride Chemical compound Cl.C1=CC=CC2=NC(C=3C=C(C=4NC(=O)CCC=4C=3)C)=CN21 QGMUHSFQVFTNGH-UHFFFAOYSA-N 0.000 description 1
- NOFIZSRWDBCZOP-UHFFFAOYSA-N 6-imidazo[1,2-a]pyridin-2-yl-8-methyl-3,4-dihydro-1h-quinolin-2-one Chemical compound C1=CC=CC2=NC(C=3C=C(C=4NC(=O)CCC=4C=3)C)=CN21 NOFIZSRWDBCZOP-UHFFFAOYSA-N 0.000 description 1
- JXNDVVMVKPPSCD-UHFFFAOYSA-N 8-chloro-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CC(=O)NC2=C1C=CC=C2Cl JXNDVVMVKPPSCD-UHFFFAOYSA-N 0.000 description 1
- ZFWYLZDGDQZABG-UHFFFAOYSA-N 8-chloro-6-(3-methylimidazo[1,2-a]pyridin-2-yl)-3,4-dihydro-1h-quinolin-2-one;hydrobromide Chemical compound Br.N1C(=O)CCC2=CC(C3=C(N4C=CC=CC4=N3)C)=CC(Cl)=C21 ZFWYLZDGDQZABG-UHFFFAOYSA-N 0.000 description 1
- UDKMDIKMJWOSJP-UHFFFAOYSA-N 8-hydroxy-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CC(=O)NC2=C1C=CC=C2O UDKMDIKMJWOSJP-UHFFFAOYSA-N 0.000 description 1
- XGOOUHUKXBBHMA-UHFFFAOYSA-N 8-hydroxy-5-(3-methylimidazo[1,2-a]pyridin-2-yl)-1H-quinolin-2-one hydrochloride Chemical compound Cl.N1C(=O)C=CC2=C1C(O)=CC=C2C1=C(C)N2C=CC=CC2=N1 XGOOUHUKXBBHMA-UHFFFAOYSA-N 0.000 description 1
- ZFQXIQAKTQEXSL-UHFFFAOYSA-N 8-methoxy-5-(3-methyl-6-nitroimidazo[1,2-a]pyridin-2-yl)-1h-quinolin-2-one Chemical compound C1=CC(=O)NC2=C1C(C1=C(N3C=C(C=CC3=N1)[N+]([O-])=O)C)=CC=C2OC ZFQXIQAKTQEXSL-UHFFFAOYSA-N 0.000 description 1
- ZBDYHIOUYXTODB-UHFFFAOYSA-N 8-methoxy-5-(3-methyl-6-nitroimidazo[1,2-a]pyridin-2-yl)-1h-quinolin-2-one;hydrobromide Chemical compound Br.C1=CC(=O)NC2=C1C(C1=C(N3C=C(C=CC3=N1)[N+]([O-])=O)C)=CC=C2OC ZBDYHIOUYXTODB-UHFFFAOYSA-N 0.000 description 1
- MBALHOPRAZPWOE-UHFFFAOYSA-N 8-methoxy-5-(3-methylimidazo[1,2-a]pyridin-2-yl)-1h-quinolin-2-one;hydrobromide Chemical compound Br.C1=CC(=O)NC2=C1C(C1=C(N3C=CC=CC3=N1)C)=CC=C2OC MBALHOPRAZPWOE-UHFFFAOYSA-N 0.000 description 1
- ISBMUDQARDJYTF-UHFFFAOYSA-N 8-methoxy-5-(7-methylimidazo[1,2-a]pyridin-2-yl)-1H-quinolin-2-one hydrochloride Chemical compound Cl.C1=CC(=O)NC2=C1C(C=1N=C3C=C(C)C=CN3C=1)=CC=C2OC ISBMUDQARDJYTF-UHFFFAOYSA-N 0.000 description 1
- QTLWFCRRVMJMKR-UHFFFAOYSA-N 8-methoxy-5-(7-methylimidazo[1,2-a]pyridin-2-yl)-1h-quinolin-2-one Chemical compound C1=CC(=O)NC2=C1C(C=1N=C3C=C(C)C=CN3C=1)=CC=C2OC QTLWFCRRVMJMKR-UHFFFAOYSA-N 0.000 description 1
- FUPRKQZHXFDQSI-UHFFFAOYSA-N 8-methoxy-6-nitro-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CC(=O)NC2=C1C=C([N+]([O-])=O)C=C2OC FUPRKQZHXFDQSI-UHFFFAOYSA-N 0.000 description 1
- NCQOEKMWICFEHS-UHFFFAOYSA-N 8-methyl-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CC(=O)NC2=C1C=CC=C2C NCQOEKMWICFEHS-UHFFFAOYSA-N 0.000 description 1
- OAEOMGKIYOVGPM-UHFFFAOYSA-N 8-methyl-6-(3-methylimidazo[1,2-a]pyridin-2-yl)-1h-quinolin-2-one Chemical compound N1C(=O)C=CC2=CC(C3=C(N4C=CC=CC4=N3)C)=CC(C)=C21 OAEOMGKIYOVGPM-UHFFFAOYSA-N 0.000 description 1
- REXYUQPBDQAVAG-UHFFFAOYSA-N 8-methyl-6-(3-methylimidazo[1,2-a]pyridin-2-yl)-3,4-dihydro-1h-quinolin-2-one;hydrate;hydrochloride Chemical compound O.Cl.N1C(=O)CCC2=CC(C3=C(N4C=CC=CC4=N3)C)=CC(C)=C21 REXYUQPBDQAVAG-UHFFFAOYSA-N 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- CQDPVLHMCQEUGX-UHFFFAOYSA-N C1=CC2=NC(=CN2C=C1)C3=CC(=C4C(=C3)C=CC(=O)N4)Cl Chemical compound C1=CC2=NC(=CN2C=C1)C3=CC(=C4C(=C3)C=CC(=O)N4)Cl CQDPVLHMCQEUGX-UHFFFAOYSA-N 0.000 description 1
- UVSPGTNUOOISGI-UHFFFAOYSA-N C1C(C(=O)NC2=C1C=CC=C2O)C3=CC=CC=N3 Chemical compound C1C(C(=O)NC2=C1C=CC=C2O)C3=CC=CC=N3 UVSPGTNUOOISGI-UHFFFAOYSA-N 0.000 description 1
- IICOHMNVLKUOBE-UHFFFAOYSA-N C1C(C(=O)NC2=CC=CC=C21)C(=O)CCBr Chemical compound C1C(C(=O)NC2=CC=CC=C21)C(=O)CCBr IICOHMNVLKUOBE-UHFFFAOYSA-N 0.000 description 1
- IAFBUSKBDRFZFG-UHFFFAOYSA-N CC1=C(N=C2N1C=CC=C2)C3=CC4=C(C=C3)N(C(=O)C=C4)C Chemical compound CC1=C(N=C2N1C=CC=C2)C3=CC4=C(C=C3)N(C(=O)C=C4)C IAFBUSKBDRFZFG-UHFFFAOYSA-N 0.000 description 1
- LVCDGFYGKSKNDR-UHFFFAOYSA-N CC1=C(N=C2N1C=CC=C2)C3=CC4=C(C=C3)NC(=O)C=C4 Chemical compound CC1=C(N=C2N1C=CC=C2)C3=CC4=C(C=C3)NC(=O)C=C4 LVCDGFYGKSKNDR-UHFFFAOYSA-N 0.000 description 1
- LYLLNOIZVFBSLS-UHFFFAOYSA-N COC1=C2C(=CC(=C1)C3=CN4C=CC=CC4=N3)C=CC(=O)N2 Chemical compound COC1=C2C(=CC(=C1)C3=CN4C=CC=CC4=N3)C=CC(=O)N2 LYLLNOIZVFBSLS-UHFFFAOYSA-N 0.000 description 1
- LBLPZBBBNQYGHO-UHFFFAOYSA-N COC1=CC=CC2=C1NC(=O)C(=C2)C3=CC=CC=N3 Chemical compound COC1=CC=CC2=C1NC(=O)C(=C2)C3=CC=CC=N3 LBLPZBBBNQYGHO-UHFFFAOYSA-N 0.000 description 1
- VVOZQVXRFYHVJD-UHFFFAOYSA-N COC1=CC=CC2=C1NC(=O)C(C2)C3=CC=CC=N3 Chemical compound COC1=CC=CC2=C1NC(=O)C(C2)C3=CC=CC=N3 VVOZQVXRFYHVJD-UHFFFAOYSA-N 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 101100384964 Dictyostelium discoideum cxeA gene Proteins 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical class CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- YZCKVEUIGOORGS-UHFFFAOYSA-N Hydrogen atom Chemical class [H] YZCKVEUIGOORGS-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical class OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- AZFNGPAYDKGCRB-XCPIVNJJSA-M [(1s,2s)-2-amino-1,2-diphenylethyl]-(4-methylphenyl)sulfonylazanide;chlororuthenium(1+);1-methyl-4-propan-2-ylbenzene Chemical compound [Ru+]Cl.CC(C)C1=CC=C(C)C=C1.C1=CC(C)=CC=C1S(=O)(=O)[N-][C@@H](C=1C=CC=CC=1)[C@@H](N)C1=CC=CC=C1 AZFNGPAYDKGCRB-XCPIVNJJSA-M 0.000 description 1
- DRZIJQLWWHCAIT-UHFFFAOYSA-N [2-(8-methoxy-2-oxo-1h-quinolin-5-yl)imidazo[1,2-a]pyridin-3-yl]methyl-trimethylazanium;iodide Chemical compound [I-].C1=CC(=O)NC2=C1C(C1=C(N3C=CC=CC3=N1)C[N+](C)(C)C)=CC=C2OC DRZIJQLWWHCAIT-UHFFFAOYSA-N 0.000 description 1
- GUIRKVGTTAHSMI-UHFFFAOYSA-N [2-(8-methoxy-2-oxo-1h-quinolin-5-yl)imidazo[1,2-a]pyridin-3-yl]methyl-trimethylazanium;iodide;trihydrate Chemical compound O.O.O.[I-].C1=CC(=O)NC2=C1C(C1=C(N3C=CC=CC3=N1)C[N+](C)(C)C)=CC=C2OC GUIRKVGTTAHSMI-UHFFFAOYSA-N 0.000 description 1
- TZVSZBFIFHUPJF-UHFFFAOYSA-N acetaldehyde;aminourea Chemical compound CC=O.NNC(N)=O TZVSZBFIFHUPJF-UHFFFAOYSA-N 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229910001963 alkali metal nitrate Inorganic materials 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229950011175 aminopicoline Drugs 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- RNLQIBCLLYYYFJ-UHFFFAOYSA-N amrinone Chemical compound N1C(=O)C(N)=CC(C=2C=CN=CC=2)=C1 RNLQIBCLLYYYFJ-UHFFFAOYSA-N 0.000 description 1
- 229960002105 amrinone Drugs 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000006502 antiplatelets effects Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- YHASWHZGWUONAO-UHFFFAOYSA-N butanoyl butanoate Chemical compound CCCC(=O)OC(=O)CCC YHASWHZGWUONAO-UHFFFAOYSA-N 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000006309 butyl amino group Chemical group 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N butyric aldehyde Natural products CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 description 1
- QGJOPFRUJISHPQ-NJFSPNSNSA-N carbon disulfide-14c Chemical compound S=[14C]=S QGJOPFRUJISHPQ-NJFSPNSNSA-N 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 125000006355 carbonyl methylene group Chemical group [H]C([H])([*:2])C([*:1])=O 0.000 description 1
- 239000002371 cardiac agent Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- FMWMEQINULDRBI-UHFFFAOYSA-L copper;sulfite Chemical compound [Cu+2].[O-]S([O-])=O FMWMEQINULDRBI-UHFFFAOYSA-L 0.000 description 1
- 101150004389 cox5 gene Proteins 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 150000008050 dialkyl sulfates Chemical class 0.000 description 1
- 239000012973 diazabicyclooctane Substances 0.000 description 1
- DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 description 1
- 229940008406 diethyl sulfate Drugs 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 1
- 229960001008 heparin sodium Drugs 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001245 hexylamino group Chemical group [H]N([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000003707 hexyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000000297 inotrophic effect Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229960001317 isoprenaline Drugs 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 229940102396 methyl bromide Drugs 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 150000002826 nitrites Chemical class 0.000 description 1
- JCZMXVGQBBATMY-UHFFFAOYSA-N nitro acetate Chemical compound CC(=O)O[N+]([O-])=O JCZMXVGQBBATMY-UHFFFAOYSA-N 0.000 description 1
- JBCXQJHXIYZCNI-UHFFFAOYSA-N nitro benzoate Chemical compound [O-][N+](=O)OC(=O)C1=CC=CC=C1 JBCXQJHXIYZCNI-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 125000004115 pentoxy group Chemical group [*]OC([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000004894 pentylamino group Chemical group C(CCCC)N* 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- UXCDUFKZSUBXGM-UHFFFAOYSA-N phosphoric tribromide Chemical compound BrP(Br)(Br)=O UXCDUFKZSUBXGM-UHFFFAOYSA-N 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 230000009090 positive inotropic effect Effects 0.000 description 1
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- 239000004304 potassium nitrite Substances 0.000 description 1
- 235000010289 potassium nitrite Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000012746 preparative thin layer chromatography Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000006308 propyl amino group Chemical group 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- ZXZKYYHTWHJHFT-UHFFFAOYSA-N quinoline-2,8-diol Chemical compound C1=CC(=O)NC2=C1C=CC=C2O ZXZKYYHTWHJHFT-UHFFFAOYSA-N 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 210000001013 sinoatrial node Anatomy 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- HIFJUMGIHIZEPX-UHFFFAOYSA-N sulfuric acid;sulfur trioxide Chemical compound O=S(=O)=O.OS(O)(=O)=O HIFJUMGIHIZEPX-UHFFFAOYSA-N 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000006318 tert-butyl amino group Chemical group [H]N(*)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000003866 tertiary ammonium salts Chemical class 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 1
- CVQPQLRQAKXFFF-UHFFFAOYSA-N trihydrate;trihydrochloride Chemical compound O.O.O.Cl.Cl.Cl CVQPQLRQAKXFFF-UHFFFAOYSA-N 0.000 description 1
- SZJJKXXVMLBTSG-UHFFFAOYSA-K tripotassium;carbonate;hydroxide Chemical compound [OH-].[K+].[K+].[K+].[O-]C([O-])=O SZJJKXXVMLBTSG-UHFFFAOYSA-K 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
- C07D215/28—Alcohols; Ethers thereof with halogen atoms or nitro radicals in positions 5, 6 or 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
- C07D215/32—Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15901680 | 1980-11-11 | ||
| JP55159016A JPS5782390A (en) | 1980-11-11 | 1980-11-11 | Carbostyril derivative |
| JP55179950A JPS57102888A (en) | 1980-12-18 | 1980-12-18 | Carbostyril derivative |
| JP17995080 | 1980-12-18 | ||
| JP8100328 | 1981-11-11 | ||
| PCT/JP1981/000328 WO1982001706A1 (en) | 1980-11-11 | 1981-11-11 | Carbostyril compounds,composition containing same,and process for their preparation |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI822471L FI822471L (fi) | 1982-07-12 |
| FI822471A0 FI822471A0 (fi) | 1982-07-12 |
| FI71145B FI71145B (fi) | 1986-08-14 |
| FI71145C true FI71145C (fi) | 1986-11-24 |
Family
ID=26485945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI822471A FI71145C (fi) | 1980-11-11 | 1982-07-12 | Foerfarande foer framstaellning av imidazo/1,2-a/-pyridin-2-yl-karbostyrilderivat vilka aer anvaendbara som hjaertmedicin |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4414390A (no) |
| EP (1) | EP0052016B1 (no) |
| KR (1) | KR880001657B1 (no) |
| AT (1) | AT382376B (no) |
| AU (1) | AU547586B2 (no) |
| CA (1) | CA1164459A (no) |
| CH (1) | CH653684A5 (no) |
| DE (1) | DE3152512T1 (no) |
| DK (1) | DK157193C (no) |
| ES (1) | ES507545A0 (no) |
| FI (1) | FI71145C (no) |
| IT (1) | IT8149680A0 (no) |
| MX (1) | MX6802E (no) |
| NO (1) | NO157819C (no) |
| PH (1) | PH17158A (no) |
| PT (1) | PT73959B (no) |
| SE (1) | SE440653B (no) |
| SU (1) | SU1215621A3 (no) |
| WO (1) | WO1982001706A1 (no) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4636502A (en) * | 1982-12-27 | 1987-01-13 | Eli Lilly And Company | Methods of producing a positive inotropic effect or vasodilation by administration of 2-phenyl imidazo pyrimidines and pyrazines |
| US4537889A (en) * | 1982-12-27 | 1985-08-27 | Eli Lilly And Company | Inotropic agents |
| GB8305245D0 (en) * | 1983-02-25 | 1983-03-30 | Fujisawa Pharmaceutical Co | Imidazo-heterocyclic compounds |
| US4533734A (en) * | 1983-11-10 | 1985-08-06 | Eli Lilly And Company | Inotropic agents |
| PT79699B (en) * | 1983-12-22 | 1986-12-10 | Pfizer | Process for preparing quinolone inotropic agents |
| PT80533B (en) * | 1984-05-29 | 1987-04-06 | Pfizer | Process for preparing quinolone inotropic agents |
| US4721721A (en) * | 1984-12-18 | 1988-01-26 | Rorer Pharmaceutical Corporation | 6-(4-thiazole) compounds, cardiotonic compositions including the same, and their uses |
| FR2580646A1 (fr) * | 1985-04-19 | 1986-10-24 | Synthelabo | Derives de 2(1h)-quinolinone, leur preparation et leur application en therapeutique |
| US4666913A (en) * | 1985-11-22 | 1987-05-19 | William H. Rorer, Inc. | Hydroxy and aminothiazolyl-benzodiazinone compounds, cardiotonic compositions including the same, and their uses |
| GB8529362D0 (en) * | 1985-11-28 | 1986-01-02 | Pfizer Ltd | Quinolone cardiac stimulants |
| GB8619902D0 (en) * | 1986-08-15 | 1986-09-24 | Pfizer Ltd | Quinolone cardiac stimulants |
| GB8709448D0 (en) * | 1987-04-21 | 1987-05-28 | Pfizer Ltd | Heterobicyclic quinoline derivatives |
| WO1995035296A1 (en) * | 1994-06-20 | 1995-12-28 | Takeda Chemical Industries, Ltd. | Condensed imidazole compounds, their production and use |
| DE10117184A1 (de) * | 2001-04-05 | 2002-10-17 | Gruenenthal Gmbh | Substituierte Imidazol[1,2-a]-pyridin-3-yl-amid- und -aminverbindungen |
| DE10247271A1 (de) * | 2002-10-10 | 2004-08-26 | Grünenthal GmbH | Substituierte C-Imidazo[1,2-a]pyridin-3-yle |
| PE20050211A1 (es) * | 2003-04-02 | 2005-04-27 | Novartis Ag | Procedimiento para preparar oxi-(1h)-quinolin-2-onas 5-(alfa-haloacetil)-8-sustituidas |
| DE102005019181A1 (de) * | 2005-04-25 | 2006-10-26 | Novartis Ag | Peptid-Deformylase (PDF) Inhibitoren 1 |
| WO2010032195A1 (en) | 2008-09-16 | 2010-03-25 | Csir | Imidazopyridines and imidazopyrimidines as hiv-i reverse transcriptase inhibitors |
| ES2362894B1 (es) * | 2009-11-16 | 2012-05-21 | Ferrer Internacional S.A. | Procedimiento de preparación del �?cido 4-nitro-oxi-metil-benzoico. |
| US10188108B2 (en) | 2015-04-08 | 2019-01-29 | Bayer Cropscience Aktiengesellschaft | Fused bicyclic heterocycle derivatives as pesticides |
| KR20180030913A (ko) | 2015-07-30 | 2018-03-26 | 브리스톨-마이어스 스큅 컴퍼니 | 아릴 치환된 비시클릭 헤테로아릴 화합물 |
| WO2018013774A1 (en) * | 2016-07-14 | 2018-01-18 | Bristol-Myers Squibb Company | Bicyclic heteroaryl substituted compounds |
| US20190315774A1 (en) | 2016-07-14 | 2019-10-17 | Bristol-Myers Squibb Company | Tricyclic heteroaryl-substituted quinoline and azaquinoline compounds as par4 inhibitors |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1473819A (en) * | 1976-01-28 | 1977-05-18 | Gallardo Antonio Sa | Derivatives of imidazo 1,2-a pyridine |
| EP0007525A1 (de) * | 1978-07-18 | 1980-02-06 | Hoechst Aktiengesellschaft | 2-(4-Aminopiperidino)-3,4-dihydrochinoline, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen sowie ihre Verwendung |
| ES482439A0 (es) * | 1978-07-18 | 1980-04-01 | Hoechst Ag | Procedimiento para la preparacion de nuevos derivados de 1-(4-aminopiperidino)-3,4-dihidroisoquinoleina. |
| JPS5553284A (en) * | 1978-10-12 | 1980-04-18 | Yoshitomi Pharmaceut Ind Ltd | Pyridazinone derivative |
| GB2031404A (en) * | 1978-10-17 | 1980-04-23 | Yoshitomi Pharmaceutical | Pyridazinone compounds |
-
1981
- 1981-10-29 CA CA000389034A patent/CA1164459A/en not_active Expired
- 1981-11-10 PH PH26478A patent/PH17158A/en unknown
- 1981-11-10 PT PT73959A patent/PT73959B/pt not_active IP Right Cessation
- 1981-11-11 WO PCT/JP1981/000328 patent/WO1982001706A1/ja active IP Right Grant
- 1981-11-11 KR KR1019810004359A patent/KR880001657B1/ko active
- 1981-11-11 US US06/403,582 patent/US4414390A/en not_active Expired - Lifetime
- 1981-11-11 DE DE813152512T patent/DE3152512T1/de active Granted
- 1981-11-11 MX MX819760U patent/MX6802E/es unknown
- 1981-11-11 IT IT8149680A patent/IT8149680A0/it unknown
- 1981-11-11 ES ES507545A patent/ES507545A0/es active Granted
- 1981-11-11 AT AT0908381A patent/AT382376B/de not_active IP Right Cessation
- 1981-11-11 CH CH4324/82A patent/CH653684A5/fr not_active IP Right Cessation
- 1981-11-11 AU AU78085/81A patent/AU547586B2/en not_active Ceased
- 1981-11-11 EP EP81305344A patent/EP0052016B1/en not_active Expired
-
1982
- 1982-07-08 DK DK307482A patent/DK157193C/da not_active IP Right Cessation
- 1982-07-08 SE SE8204237A patent/SE440653B/sv not_active IP Right Cessation
- 1982-07-09 NO NO82822391A patent/NO157819C/no unknown
- 1982-07-11 SU SU823466402A patent/SU1215621A3/ru active
- 1982-07-12 FI FI822471A patent/FI71145C/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FI822471L (fi) | 1982-07-12 |
| NO822391L (no) | 1982-07-09 |
| WO1982001706A1 (en) | 1982-05-27 |
| SE8204237L (sv) | 1982-07-08 |
| PH17158A (en) | 1984-06-13 |
| DK307482A (da) | 1982-07-08 |
| FI822471A0 (fi) | 1982-07-12 |
| PT73959B (en) | 1983-04-18 |
| US4414390A (en) | 1983-11-08 |
| EP0052016A1 (en) | 1982-05-19 |
| EP0052016B1 (en) | 1984-09-05 |
| CA1164459A (en) | 1984-03-27 |
| KR880001657B1 (ko) | 1988-09-05 |
| SE8204237D0 (sv) | 1982-07-08 |
| ES8301967A1 (es) | 1983-02-01 |
| NO157819C (no) | 1988-05-25 |
| DE3152512T1 (de) | 1982-11-18 |
| AU7808581A (en) | 1982-06-07 |
| AT382376B (de) | 1987-02-25 |
| KR830007644A (ko) | 1983-11-04 |
| DK157193C (da) | 1990-04-09 |
| SU1215621A3 (ru) | 1986-02-28 |
| DK157193B (da) | 1989-11-20 |
| MX6802E (es) | 1986-07-29 |
| SE440653B (sv) | 1985-08-12 |
| NO157819B (no) | 1988-02-15 |
| IT8149680A0 (it) | 1981-11-11 |
| FI71145B (fi) | 1986-08-14 |
| CH653684A5 (fr) | 1986-01-15 |
| DE3152512C2 (no) | 1991-01-03 |
| AU547586B2 (en) | 1985-10-24 |
| ATA908381A (de) | 1986-07-15 |
| ES507545A0 (es) | 1983-02-01 |
| PT73959A (en) | 1981-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI71145B (fi) | Foerfarande foer framstaellning av imidazo/1,2-a/-pyridin-2-yl-karbostyrilderivat vilka aer anvaendbara som hjaertmedicin | |
| EP0467248B1 (en) | Pyrazolopyridine compound and processes for preparation thereof | |
| FI77450C (fi) | Foerfarande foer framstaellning av piperazinylsubstituerade karbostyrilderivat, vilka aer anvaendbara som kardiotoniska medel. | |
| DK164451B (da) | 3-aminoquinolinderivat | |
| CZ342595A3 (en) | Purine derivatives, process of their preparation and pharmaceutical compositions containing thereof | |
| NZ517324A (en) | 5-(2-substituted-5-heterocyclylsulphonylpyrid-3-YL)- dihydropyrazolo[4,3-d]pyrimidin-7-ones as phosphodiesterase inhibitors | |
| NO318213B1 (no) | Fremgangsmate til fremstilling av imidazokinolinaminer | |
| EP0120589A1 (en) | Imidazo-heterocyclic compounds, processes for preparation thereof and pharmaceutical composition comprising the same | |
| FI65260B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara 3-1h-tetrazol-5-yl)-4h-pyrimido(2,1-b)benzotiazolderivat | |
| HUT52092A (en) | Process for producing 2(1h)-quinolinone derivatives and pharmaceutical compositions comprising same | |
| CA2186086A1 (en) | Substituted xanthines | |
| NO842684L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater | |
| WO2002083683A9 (en) | Novel tricyclic pyridyl benzazepine carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists | |
| EP0874849B1 (en) | 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives | |
| HU197749B (en) | Process for producing /3,4-d/pyrimidine derivatives and pharmaceutical compositions comprising these compounds as active ingredient | |
| US4463007A (en) | Triazoloquinazolinones, and compositions and methods for treating allergic disorders with them | |
| JP2997828B2 (ja) | キノリン及びナフチリジン誘導体 | |
| NL192040C (nl) | Carbostyrilverbindingen en preparaat dat een dergelijke verbinding bevat. | |
| EP0107455A1 (en) | Triazoloquinoxalines as antidepressants and antifatigue agents | |
| US5334595A (en) | Pyrazoloquinolones as anticancer agents | |
| FI77035C (fi) | Foerfarande foer framstaellning av farmakologiskt verkande 5-oxo-5h-pyrido/2,1-b/1h-triazolo/4,5-g/- och /4,5-f/-kinazoliner. | |
| WO2003004494A1 (en) | Pyridazinone compound as adenosine antagonists | |
| US20240092780A1 (en) | Adducts and dimer compounds synthesized using gk method | |
| CS248711B2 (en) | Production method of the/l1,2,4/triazol/4,3-a/chinoxaline-4-amin derivatives | |
| JPH0133083B2 (no) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed | ||
| MM | Patent lapsed |
Owner name: OTSUKA PHARMACEUTICAL CO. LTD. |